Company Profile

Hikma Pharmaceuticals plc (OTC: HKMPY)
7:43 PM UTC, 07/02/24
Last: $48.05 Change: +0.48 %Change: +1.00% Volume: 827
Detailed Quote
Open: $ 47.59   Volume: 827
High: $ 48.05   Yield(%) 2.99
Low: $ 47.59   P/E Ratio (ttm): 27.19
Dividend ($): 0.92   Market Cap ($): 5.19B
EPS ($) n/a   Shares Out: 110.94M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -7.76
% Price Change (last 13 weeks): -1.01
% Price Change (last 26 weeks): 3.70
% Price Change (last 52 weeks): -2.69
% Price Change (year to date): 2.56
Management Effectiveness
Return on Equity (%): 8.77
Return on Assets (%): 4.15
Return on Invested Capital (%): 12.82
Profitability
Gross Profit Margin (%): 46.47
Net Profit Margin (%): 6.61
Operating Profit Margin (%): 17.08
Price & Volume
50-day Moving Average: $15.92
200-day Moving Average: $17.22
Avg. Daily Vol. (last 50 days): 711
Avg. Daily Vol. (last 200 days): 416
52-wk high: $56.63
52-wk low: $42.23
Bid: $n/a
Ask: $n/a
Company Information
Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products. It operates through the following segments: Branded, Injectables, Generics, and Others. The Branded segment sells branded generics and in-licensed patented products in the Middle East and North Africa. The Injectables segment includes generic injectable products distributed globally and primarily used in hospitals. The Generics segment focuses on oral and other non-injectable generic products, and is sold in the U.S. retail market. The Others segment comprises of Arab Medical Containers Ltd., International Pharmaceutical Research Center Ltd., and the chemicals division of Hikma Pharmaceuticals Ltd. (Jordan). The company was founded by Samih Taleb Darwazah in 1978 and is headquartered in London, the United Kingdom.
Hikma Pharmaceuticals plc
1 New Burlington Place
London GL W1S 2HR

Phone: 44.20.7399.2760
Fax: 44.20.7399.2761
http://www.hikma.com
Per Share Data
Earnings (1year) ($): 1.72
Annual Dividend ($): 1.40
Current P/E Ratio (ttm): 27.19
Book Value ($): 19.88
Cash Flow ($): 3.45
Valuation Ratios
Price/Earnings (x): 27.19
Price/Sales (x): 1.76
Price/Book (x): 2.29
Price/Cash Flow (x): 9.51
Financial Strength
Quick Ratio (x): 0.90
Current Ratio (x): 1.57
LT Debt/Equity (x): 46.86
Total Debt/Equity (x): 54.19



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.